Rare diseases
Investigational molecules
Locations
Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Metastatic Prostate Cancer
ItalyStudy of palbociclib with hormone therapy versus hormone therapy alone in patients with recurrent hormone receptor-positive/HER2-negative breast cancer after surgery
ItalyStudy of Zanubrutinib and Obinutuzumab for Patients with Relapsed or Refractory Follicular Lymphoma
ItalyStudy on the Safety and Effectiveness of Quizartinib for Children and Young Adults with Acute Myeloid Leukemia (AML)
ItalyStudy on Encorafenib, Cetuximab, and FOLFIRI for Patients with BRAF V600E Mutated Metastatic Colorectal Cancer After Progression on Encorafenib and Cetuximab
ItalyStudy on the Safety and Effectiveness of Rilzabrutinib for Adults and Adolescents with Persistent or Chronic Immune Thrombocytopenia (ITP)
ItalyStudy on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis
ItalyA Phase 4 Study of Crizanlizumab Treatment for Patients with Sickle Cell Disease Who Previously Participated in Novartis Clinical Trials
ItalyStudy Comparing Nivolumab, Nivolumab with Ipilimumab, or Chemotherapy for Patients with Metastatic Colorectal Cancer with High Microsatellite Instability
ItalyStudy on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment
ItalyStudy Comparing Pralsetinib and Standard Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer
ItalyStudy on the Safety and Effectiveness of Ibrutinib for Children and Young Adults with Chronic Graft Versus Host Disease
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
